Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ling Zhi Wang
Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-To-Mesenchymal Transition in Hepatocellular Carcinoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Cx32 Reverses Epithelial-Mesenchymal Transition in Doxorubicin-Resistant Hepatocellular Carcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
Epigenetics of Epithelial-To-Mesenchymal Transition in Pancreatic Carcinoma
International Journal of Cancer
Cancer Research
Oncology
Inhibition of ZIP4 Reverses Epithelial-To-Mesenchymal Transition and Enhances the Radiosensitivity in Human Nasopharyngeal Carcinoma Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Inhibition of cyclinB1 Suppressed the Proliferation, Invasion, and Epithelial Mesenchymal Transition of Hepatocellular Carcinoma Cells and Enhanced the Sensitivity to TRAIL-Induced Apoptosis
OncoTargets and Therapy
Oncology
Pharmacology
LncRNA HULC Enhances Epithelial-Mesenchymal Transition to Promote Tumorigenesis and Metastasis of Hepatocellular Carcinoma via the miR-200a-3p/ZEB1 Signaling Pathway
Oncotarget
Oncology
STAT3 Cooperates With Twist to Mediate Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma Cells
Oncology Reports
Medicine
Cancer Research
Oncology
FAM 134B Induces Tumorigenesis and Epithelial‐to‐mesenchymal Transition via Akt Signaling in Hepatocellular Carcinoma
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Metadherin Promotes Hepatocellular Carcinoma Metastasis Through Induction of Epithelial-Mesenchymal Transition
Clinical Cancer Research
Cancer Research
Oncology
HCRP1 Inhibits TGF-β Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
International Journal of Oncology
Cancer Research
Oncology
